252 related articles for article (PubMed ID: 15275766)
1. Relative analgesic potency of fentanyl and sufentanil during intermediate-term infusions in patients after long-term opioid treatment for chronic pain.
Reynolds L; Rauck R; Webster L; DuPen S; Heinze E; Portenoy R; Katz N; Charapata S; Wallace M; Fisher DM
Pain; 2004 Jul; 110(1-2):182-8. PubMed ID: 15275766
[TBL] [Abstract][Full Text] [Related]
2. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
3. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
4. A review of intrathecal fentanyl and sufentanil for the treatment of chronic pain.
Waara-Wolleat KL; Hildebrand KR; Stewart GR
Pain Med; 2006; 7(3):251-9. PubMed ID: 16712626
[TBL] [Abstract][Full Text] [Related]
5. Increased analgesic potency of mu agonists after continuous naloxone infusion in rats.
Paronis CA; Holtzman SG
J Pharmacol Exp Ther; 1991 Nov; 259(2):582-9. PubMed ID: 1658305
[TBL] [Abstract][Full Text] [Related]
6. A comparison of fentanyl and sufentanil in patients undergoing coronary artery bypass graft surgery.
Thomson IR; Harding G; Hudson RJ
J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):652-6. PubMed ID: 11139103
[TBL] [Abstract][Full Text] [Related]
7. Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses.
Martucci C; Panerai AE; Sacerdote P
Pain; 2004 Jul; 110(1-2):385-92. PubMed ID: 15275790
[TBL] [Abstract][Full Text] [Related]
8. Preliminary results of prolonged target controlled infusion of sufentanil adjusted to an effort pain score after cardiac surgery.
Bastin R; Barvais L; Mélot C; Vincent JL; Berré J
Acta Anaesthesiol Belg; 2005; 56(1):31-6. PubMed ID: 15822418
[TBL] [Abstract][Full Text] [Related]
9. [Level concept of analgesic dosing in intensive care medicine with sufentanil].
Wappler F; Scholz J; Prause A; Möllenberg O; Bause H; Schulte am Esch J
Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Jan; 33(1):8-26. PubMed ID: 9530479
[TBL] [Abstract][Full Text] [Related]
10. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T
Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
[TBL] [Abstract][Full Text] [Related]
12. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
Sittl R; Likar R; Nautrup BP
Clin Ther; 2005 Feb; 27(2):225-37. PubMed ID: 15811486
[TBL] [Abstract][Full Text] [Related]
13. Comparison of analgesic effects of morphine, fentanyl, and remifentanil with intravenous patient-controlled analgesia after cardiac surgery.
Gurbet A; Goren S; Sahin S; Uckunkaya N; Korfali G
J Cardiothorac Vasc Anesth; 2004 Dec; 18(6):755-8. PubMed ID: 15650986
[TBL] [Abstract][Full Text] [Related]
14. Sufentanil is not superior to morphine for the treatment of acute traumatic pain in an emergency setting: a randomized, double-blind, out-of-hospital trial.
Bounes V; Barthélémy R; Diez O; Charpentier S; Montastruc JL; Ducassé JL
Ann Emerg Med; 2010 Nov; 56(5):509-16. PubMed ID: 20382445
[TBL] [Abstract][Full Text] [Related]
15. A Phase III study to assess the clinical utility of low-dose fentanyl transdermal system in patients with chronic nonmalignant pain.
Otis J; Rothman M
Curr Med Res Opin; 2006 Aug; 22(8):1493-501. PubMed ID: 16870074
[TBL] [Abstract][Full Text] [Related]
16. A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer.
Portenoy RK; Taylor D; Messina J; Tremmel L
Clin J Pain; 2006; 22(9):805-11. PubMed ID: 17057563
[TBL] [Abstract][Full Text] [Related]
17. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
[TBL] [Abstract][Full Text] [Related]
18. Effect of local administration of transdermal fentanyl on peripheral opioid analgesia.
Worrich S; Schuler G; Janicki PK
Pain Med; 2007; 8(1):41-7. PubMed ID: 17244103
[TBL] [Abstract][Full Text] [Related]
19. Comparison of sufentanil versus fentanyl in ventilated term neonates.
Schmidt B; Adelmann C; Stützer H; Welzing L; Hünseler C; Kribs A; Roth B
Klin Padiatr; 2010 Mar; 222(2):62-6. PubMed ID: 19731193
[TBL] [Abstract][Full Text] [Related]
20. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
Sorge J; Sittl R
Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
